Summary

Eligibility
for people ages 18 months to 5 years (full criteria)
Location
at UCLA
Dates
study started
completion around
Principal Investigator
by Catherine Lord (ucla)

Description

Summary

Research teams in Boston University, UCLA, and Weill Cornell will recruit 90 participants in 3 years (10 participants per site per year) and evaluate JASPER, play-based intervention, using the BOSCC and ELSA-T. Participants will be randomized to receive JASPER facilitated either by a clinician or the caregiver. After 10 weeks, the participants will be evaluated using the CGI to determine if they are "responders" or "non-responders". Nonresponders will be given a mix of clinician and caregiver-facilitated JASPER and responders will remain the course for the following 10 weeks. Coding of the BOSCC and ELSA-T will be the outcome measures and change will be evaluated throughout the study.

Details

Keywords

Autism Spectrum Disorder, BOSCC, ELSA-T, JASPER, autism, clinician-mediated JASPER, parent-mediated JASPER

Eligibility

Locations

  • UCLA accepting new patients
    Los Angeles California 90095-1406 United States
  • Semel Institute not yet accepting patients
    Los Angeles California 90095 United States
  • Weill Cornell Medical College/New York Presbyterian Hospital not yet accepting patients
    White Plains New York 10605 United States
  • Boston University not yet accepting patients
    Boston Massachusetts 02215 United States

Lead Scientist at University of California Health

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, Los Angeles
ID
NCT04146428
Study Type
Interventional
Participants
Expecting 90 study participants
Last Updated